60 Degrees Pharmaceuticals, Inc. (SXTP): Revenue
$1.01M
Year ended 2025-12-31
$1.11M
Trailing 12 months to 2026-06-30
+65.2%
3-year compound annual growth
| Period ended | Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $1.01M | +65.5% | 2026-03-30, From 2025-01-01 |
| 2024-12-31 | $607.6K | +139.6% | 2026-03-30, From 2024-01-01 |
| 2023-12-31 | $253.6K | +13.6% | 2025-03-27, From 2023-01-01 |
| 2022-12-31 | $223.2K | n/a | 2024-04-01, From 2022-01-01 |
Revenue at similar companies
| Company | Year ended | Revenue | Change YoY |
|---|---|---|---|
| 60 Degrees Pharmaceuticals, Inc. (SXTP) | 2025-12-31 | $1.01M | +65.5% |
| Shattuck Labs, Inc. (STTK) | 2025-12-31 | $1.00M | -82.5% |
| Dare Bioscience, Inc. (DARE) | 2025-12-31 | $1.03M | n/m |
| Rafael Holdings, Inc. (RFL) | 2025-07-31 | $917.0K | +44.0% |
| Bespoke Extracts, Inc. (BSPK) | 2024-12-31 | $1.12M | +42.3% |
| China SXT Pharmaceuticals, Inc. (SXTC) | 2026-03-31 | $1.14M | -34.6% |
| Neuphoria Therapeutics Inc. (NEUP) | 2026-06-30 | $1.17M | -92.5% |
| Rallybio Corp (RLYB) | 2025-12-31 | $858.0K | +34.9% |
| Longeveron Inc. (LGVN) | 2025-12-31 | $1.20M | -49.9% |
Compare SXTP, STTK, DARE, RFL side by side · Screen every company in Pharmaceutical Preparations ↗